Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome

NATerminatedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

February 28, 2009

Conditions
Hepatorenal SyndromeRenal FailureLiver Diseases
Interventions
PROCEDURE

Blood Draws and a hepatectomy specimen

"Pre operative blood draw(1.5 ml serum, 1.5 ml EDTA)(approximately 2 teaspoons).~Blood draw during surgery(1.5 ml serum, 1.5 ml EDTA)from Hepatic Artery, Hepatic Vein, and Portal Vein.~Wedge section of Hepatectomy specimen following resection in surgical subjects(tested for the same factors)"

PROCEDURE

Blood draw - pre operative standard of care

Pre-operative blood draw(1.5 ml serum, 1.5 ml EDTA)(approximately 2 teaspoons) from peripheral vein

Trial Locations (1)

01805

Lahey Clinic, Inc., Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Dr. Vikas Sukhatme

UNKNOWN

lead

Lahey Clinic

OTHER